SCHEMBL5048338

SCHEMBL5048338

CCOc1cc(-c2cc(C(F)(F)F)n3ncc(C(=O)Nc4cccc(S(=O)(=O)N5CCOCC5)c4)c3n2)ccc1C(F)(F)F

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.61
HTT P42858 3/20 0.61
KDM4E B2RXH2 3/20 0.61
MAPK1 P28482 2/20 0.60
THRB P10828 1/20 0.49
NR1H4 Q96RI1 1/20 0.46
HPGD P15428 3/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TSHR P16473 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
NR4A1 P22736 1/20 0.45
MEN1 O00255 3/20 0.44
POLB P06746 2/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047718 0.93 KMT2A (0.72) KMT2AHTTKDM4EMAPK1THRB
SCHEMBL5132977 0.92 KMT2A (0.50) KMT2AHTTKDM4EMAPK1THRB
SCHEMBL5046436 0.89 MAPK1 (0.65) KMT2AHTTKDM4EMAPK1NR1H4
SCHEMBL5048289 0.88 THRB (0.55) KMT2AHTTKDM4EMAPK1THRB
SCHEMBL5048278 0.88 THRB (0.54) KMT2AHTTKDM4EMAPK1THRB
SCHEMBL5044906 0.87 THRB (0.53) KMT2AHTTKDM4EMAPK1THRB
SCHEMBL5045309 0.86 KDM4E (0.82) KMT2AHTTKDM4EMAPK1THRB
SCHEMBL5049526 0.86 MAPK1 (0.68) KMT2AHTTKDM4EMAPK1NR1H4
SCHEMBL5049794 0.86 MAPK1 (0.72) KMT2AHTTKDM4EMAPK1NR1H4
SCHEMBL5040836 0.85 THRB (0.51) KMT2AHTTKDM4EMAPK1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378417-B2 Pyrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US claimed
US-20050282827-A1 Pyrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 US claimed
US-7378417-B2 Pyrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US disclosed
US-20050282827-A1 Pyrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282827-A1 Pyrazolo-pyrimidine derivatives P2RX3, P2RX1, P2RX5 KMT2A 3706/4885HTT 2091/4885KDM4E 3638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.